Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vivani Medical Inc VANI

Vivani Medical, Inc. is a preclinical-stage biopharmaceutical company. The Company develops miniaturized and subdermal implants utilizing its NanoPortal technology to enable the delivery of a range of medicines to treat chronic diseases. It is engaged in the development of the Company’s lead programs NPM-115 and NPM-119, is a GLP-1 implant candidates for the treatment of chronic weight... see more

Recent & Breaking News (NDAQ:VANI)

Second Sight Medical Products Announces Successful Completion of its Merger with Nano Precision Medical and its Name Change to Vivani Medical, Inc.

Business Wire August 30, 2022

Second Sight Medical Products, Inc. Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, Inc. and other Results of 2022 Annual Meeting

Business Wire July 29, 2022

Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study

Business Wire July 18, 2022

Nano Precision Medical Co-Founder and CEO Discusses Proposed Second Sight Merger in Interview to Air on Bloomberg U.S. on the RedChip Money Report®

Business Wire April 14, 2022

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates ECOL, ZWS, MGI, TLMD, EYES

PR Newswire February 21, 2022

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Second Sight Medical Products, Inc. Merger

Newsfile February 18, 2022

SECOND SIGHT MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Second Sight Medical Products, Inc. - EYES

PR Newswire February 16, 2022

Moore Kuehn Encourages BDSI, ZWS, EYES, and GIIX Investors to Contact Law Firm

PR Newswire February 15, 2022

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates ECOL, EYES, ZGNX, FLMN

PR Newswire February 14, 2022

Equity Alert - The M&A Class Action Firm is Investigating the Merger - SAVE, ECOL, EYES, VHAQ, BREZ, AKIC

PR Newswire February 12, 2022

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates SAVE, TLMD, ALJJ, ECOL, EYES

PR Newswire February 9, 2022

EYES Stock Investigation: Halper Sadeh LLP Is Investigating Whether the Merger of Second Sight Medical Products, Inc. Is Fair to Shareholders

Business Wire February 9, 2022

Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company

Business Wire February 7, 2022

Second Sight Medical Products Announces a New NIH Grant Supplement for Its Orion Study

Business Wire August 11, 2021

Second Sight Medical Products Announces Closing of Public Offering

Business Wire June 25, 2021

Second Sight Medical Products Announces Pricing of Public Offering

Business Wire June 22, 2021

Second Sight Medical Products Announces Proposed Public Offering of Common Stock

Business Wire June 22, 2021

Second Sight Medical Products Announces Results of its 2021 Annual Meeting

Business Wire June 1, 2021

Second Sight Medical Products Announces Year Three NIH Funding of Its Orion Study

Business Wire May 13, 2021

Second Sight Medical Products Announces Two-Year Results of its Orion Study

Business Wire May 12, 2021